Inspire Medical Systems EBITDA 2017-2024 | INSP
Inspire Medical Systems annual and quarterly EBITDA history from 2017 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Inspire Medical Systems EBITDA for the quarter ending September 30, 2024 was $0.014B, a 207.8% decline year-over-year.
- Inspire Medical Systems EBITDA for the twelve months ending September 30, 2024 was $0.009B, a 118.3% decline year-over-year.
- Inspire Medical Systems 2023 annual EBITDA was $-0.04B, a 12.78% decline from 2022.
- Inspire Medical Systems 2022 annual EBITDA was $-0.046B, a 18.44% increase from 2021.
- Inspire Medical Systems 2021 annual EBITDA was $-0.039B, a 30.25% decline from 2020.
| Inspire Medical Systems Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-40 |
| 2022 | $-46 |
| 2021 | $-39 |
| 2020 | $-55 |
| 2019 | $-35 |
| 2018 | $-20 |
| 2017 | $-15 |
| 2016 | $-17 |
| Inspire Medical Systems Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $14 |
| 2024-06-30 | $4 |
| 2024-03-31 | $-17 |
| 2023-12-31 | $8 |
| 2023-09-30 | $-13 |
| 2023-06-30 | $-16 |
| 2023-03-31 | $-19 |
| 2022-12-31 | $0 |
| 2022-09-30 | $-17 |
| 2022-06-30 | $-14 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-9 |
| 2021-06-30 | $-12 |
| 2021-03-31 | $-15 |
| 2020-12-31 | $-7 |
| 2020-09-30 | $-10 |
| 2020-06-30 | $-23 |
| 2020-03-31 | $-16 |
| 2019-12-31 | $-9 |
| 2019-09-30 | $-9 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-9 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-4 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-5 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $-4 |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.669B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |